Abiopharma

🔍 Gross Bradley J. (Director)

Company: Stagwell Inc (STGW)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Sold 2,163,790 shares of Class A Common Stock at $6.042 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,789.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Reflects a repurchase of shares by Stagwell Inc. (the "Issuer") pursuant to a Share Repurchase Agreement, dated May 4, 2026.
• F2: The Reporting Person is a managing director of Goldman Sachs & Co. ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). GS Group is the direct owner of Bridge Street Opportunity Advisors, L.L.C., the general partner of each of StoneBridge 2017, L.P., which directly held 1,597,531 shares of Class A Common Stock of the Issuer reported as sold herein, and StoneBridge 2017 Offshore, L.P., which directly held 566,259 shares of Class A Common Stock of the Issuer reported as sold herein. Goldman Sachs beneficially owned directly and GS Group may be deemed to have beneficially owned indirectly 8,789 shares of Class A Common Stock of the Issuer. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any.